28 patients with refractory metastatic carcinoma of the prostate were treated with cyproterone acetate (a synthetic progestin) in doses of 300 mg. daily. In 19 patients followup examinations and evaluations demonstrated beneficial results. It is believed that cyproterone acetate has an important place in the hormonal treatment of prostatic cancer.
|Original language||English (US)|
|Number of pages||3|
|Journal||Journal of Urology|
|State||Published - 1973|
ASJC Scopus subject areas